Prospects and challenges of recombinant spider venom enzymes: insights from Loxosceles and Phoneutria venom protease expressions

Spiders use chemically complex venoms to overpower prey. Such venoms are primarily composed of neurotoxic disulfide-rich peptides, linear peptides, and enzymes. The latter have received little scientific attention thus far, and despite their great translational potential, functional data on spider venom enzymes remain scarce. Hence, a more comprehensive understanding is sought, not only to provide valuable insights into their biological functionality but also to facilitate the development of novel biotechnological applications. However, their chemical isolation is prevented by the minuscule venom yields available from most spiders. Recombinant expression emerged as a promising methodology to overcome these restrictions, but comparatively few efforts have been made to establish technologies for different enzyme families. In particular, few works have explored the pivotally important technical aspects of spider venom enzyme expression, including strain selection, culture conditions, and product purification. In this study, we explore these aspects using two spider venom enzymes as a case study, with particular emphasis on the purification and refolding of an astacin-like metalloprotease from <i>Loxosceles intermedia</i> venom. The enzymes were produced as fusion proteins using diverse <i>Escherichia coli</i> strains to identify the most effective production strains, including their optimal production conditions. Thioredoxin A, a 6x-His-Tag, and a cleavage site for activated factor X allowed efficient purification and subsequent removal of all fusion tags, and we report in detail the purification of the mass spectrometry-confirmed <i>L. intermedia</i> metalloprotease from inclusion bodies. This exploratory study outlines the technical details and potential pitfalls encountered during the development of this production process and provides an important baseline for future attempts to express spider venom enzymes.

Authors

Institutions

Publication Details

Journal
Frontiers in Bioengineering and Biotechnology
Published
2025-09-19
DOI
https://doi.org/10.3389/fbioe.2025.1668774
Citations
1
Primary Topic
Venomous Animal Envenomation and Studies
Type
article
Field-Weighted Citation Impact
1.82
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prospects and challenges of recombinant spider venom enzymes: insights from Loxosceles and Phoneutria venom protease expressions

Tim Lüddecke, Josephine Dresler, Ignacio Sánchez Rodríguez, Andreas Vilcinskas et al.
1 citations
Frontiers in Bioengineering and Biotechnology
Venomous Animal Envenomation and Studies
1.82
article

Prospects and challenges of recombinant spider venom enzymes: insights from Loxosceles and Phoneutria venom protease expressions

Tim Lüddecke, Josephine Dresler, Ignacio Sánchez Rodríguez, Andreas Vilcinskas, Anne Paas, Alfredo Cabrera-Orefice
article en
1 citations

Abstract

Spiders use chemically complex venoms to overpower prey. Such venoms are primarily composed of neurotoxic disulfide-rich peptides, linear peptides, and enzymes. The latter have received little scientific attention thus far, and despite their great translational potential, functional data on spider venom enzymes remain scarce. Hence, a more comprehensive understanding is sought, not only to provide valuable insights into their biological functionality but also to facilitate the development of novel biotechnological applications. However, their chemical isolation is prevented by the minuscule venom yields available from most spiders. Recombinant expression emerged as a promising methodology to overcome these restrictions, but comparatively few efforts have been made to establish technologies for different enzyme families. In particular, few works have explored the pivotally important technical aspects of spider venom enzyme expression, including strain selection, culture conditions, and product purification. In this study, we explore these aspects using two spider venom enzymes as a case study, with particular emphasis on the purification and refolding of an astacin-like metalloprotease from <i>Loxosceles intermedia</i> venom. The enzymes were produced as fusion proteins using diverse <i>Escherichia coli</i> strains to identify the most effective production strains, including their optimal production conditions. Thioredoxin A, a 6x-His-Tag, and a cleavage site for activated factor X allowed efficient purification and subsequent removal of all fusion tags, and we report in detail the purification of the mass spectrometry-confirmed <i>L. intermedia</i> metalloprotease from inclusion bodies. This exploratory study outlines the technical details and potential pitfalls encountered during the development of this production process and provides an important baseline for future attempts to express spider venom enzymes.

Frontiers in Bioengineering and BiotechnologyVol. 13
Justus-Liebig-Universität Gießen (DE), LOEWE Centre for Translational Biodiversity Genomics (DE), Fraunhofer Institute for Molecular Biology and Applied Ecology (DE)
Openalex Percentile: Top 12%
Venomous Animal Envenomation and Studies
1.82
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.